Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes.
CONCLUSIONS: - Metformin use is associated with a lower risk of NHL compared with non-metformin antidiabetics.
PMID: 31129317 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism - Category: Endocrinology Authors: Tseng CH Tags: Diabetes Metab Source Type: research
More News: Databases & Libraries | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Health Insurance | Incretin Therapy | Insurance | Lymphoma | Metformin | Non-Hodgkin's Lymphoma | Taiwan Health